Harris & Harris Group, Inc.  

(Public, NASDAQ:TINY)   Watch this stock  
Find more results for E. Bauman
0.00 (0.00%)
Jan 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 2.51 - 3.94
Open     -
Vol / Avg. 0.00/126,580.00
Mkt cap 95.61M
P/E     -
Div/yield     -
EPS -0.35
Shares 31.25M
Beta 1.39
Inst. own 23%
Jan 15, 2015
Harris and Harris Group Inc at Needham Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -975.53% -1654.06%
Operating margin -2010.93% -1703.59%
EBITD margin - -1691.89%
Return on average assets -2.97% -6.06%
Return on average equity -3.03% -6.20%
Employees 11 -
CDP Score - -


24th Floor, 1450 Broadway
NEW YORK, NY 10018
United States - Map
+1-212-5820900 (Phone)
+1-212-5829563 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Harris & Harris Group, Inc., is an internally managed venture capital company specializing in nanotechnology and Microsystems. The Company�s investment objective is to achieve long-term capital appreciation by making venture capital investments.. The Company generally makes venture capital investments exclusively in companies commercializing or integrating products enabled by nanotechnology or microsystems. Nanotechnology is measured in nanometers, which are units of measurement in billionths of a meter. As of December 31, 2011, the Company's venture capital portfolio comprised 75.2 %of its total assets, its cash comprised 22.5 % of its total assets, and other assets comprised the remaining 2.3 %of its total assets. In July 2013, Harris and Harris Group Inc announced the closing of the sale of Xradia to Carl Zeiss.

Officers and directors

Douglas W. Jamison Chairman of the Board, Chief Executive Officer, Managing Director
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel B. Wolfe Ph.D. President, Chief Operating Officer, Managing Director
Age: 37
Bio & Compensation  - Reuters
Patricia N. Egan CPA Chief Financial Officer
Age: 39
Bio & Compensation  - Reuters
Alexei A. Andreev Ph.D. Executive Vice President, Managing Director
Age: 41
Bio & Compensation  - Reuters
Misti Ushio Ph.D. Executive Vice President, Managing Director
Age: 42
Bio & Compensation  - Reuters
Robert S. Burns Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Sandra Matrick Forman Esq. Chief Compliance Officer, General Counsel, Director - Human Resources, Corporate Secretary
Age: 47
Bio & Compensation  - Reuters
Mary P. Brady CPA Vice President, Senior Controller
Age: 52
Bio & Compensation  - Reuters
W. Dillaway Dillaway Ayres Jr. Independent Director
Age: 63
Bio & Compensation  - Reuters
Phillip A. Bauman Independent Director
Age: 58
Bio & Compensation  - Reuters